United Arab Emirates: Distribution Of Pharmaceutical Products Through A Local Partner In The GCC

Last Updated: 29 September 2016
Article by Joycia Young and Saba Al Sultani

The pharmaceutical and healthcare sector in the GCC region has over the past few years enjoyed one of the most robust growth rates in the world with an average annual growth considerably larger than that of other regions.

This growth has been driven by the expanding middle class (which has more income to spend on non-prescription healthcare products) and the continued importance placed by local governments on well-funded healthcare programs. This growth is also partly driven by the use of the GCC region as a base for expansion into nearby developing markets such as Africa and this is particularly true of manufacturers of generic drugs.

The rapid economic development in the region has also given rise to related diseases such as obesity, diabetes and cardiovascular disease. The region has a high prevalence for rare and genetic diseases. Whilst this has a negative impact on the countries and populations affected, both of these factors give the pharmaceutical industry further opportunities to grow. Despite this stellar growth, low oil prices have and will inevitably continue to affect government healthcare budgets and private healthcare programmes meaning that large price reductions across multiple therapeutic areas are to be expected. Added to this is the fact that the regulatory authorities are continuing to become more sophisticated and likely to continue to expand the regulatory regime for healthcare products.

Despite these uncertainties, the GCC continues to offer exciting opportunities for the pharmaceutical industry. In this article, we set out some of the key considerations for companies looking to expand into the region with a focus on manufacturers of pharmaceutical products who do not have a legal presence in the GCC.

Commercial Agency Laws

In general, an overseas manufacturer wishing to import pharmaceutical products into a GCC country must either have a legal presence in the relevant territory or must appoint a local agent or distributor which is approved by the regulatory authorities to import pharmaceutical products into the territory on behalf of the manufacturer.

Many of the jurisdictions across the MENA region have specific laws which give registered commercial agents certain rights as set out in those laws, the most important of which tends to be the agent's right to compensation on termination of the relationship with their principal. In general, these commercial agency laws only apply when the agent is appointed on an exclusive basis. It is not uncommon for distributors of pharmaceutical products to claim that they must be appointed on an exclusive basis in order to comply with local pharmacovigilance requirements. If this is true, the distributor could seek to register the distribution agreement with the authorities and thereby gain rights under the relevant commercial agency law.

Using the UAE as an example, the UAE commercial agencies law will only apply if the agency agreement between the agent and principal is registered in the Ministry of Economy's commercial agencies register. In order for an agency agreement to be registered with the Ministry, it must meet the minimum qualifying criteria being:

  • the agent must be a UAE national or an entity that is wholly owned by UAE nationals;
  • the agreement must grant exclusivity over all or a part of the UAE;
  • the agreement must be notarised and attested by a notary public in the jurisdiction in which it is signed and authenticated for use in the UAE; and
  • the agreement must be in Arabic, or in dual language form (e.g. English and Arabic).

Principals should note that, in the UAE, a registered commercial agent can prevent the principal's products from being distributed in the territory for which they have exclusive rights.

Marketing Authorisations

As in other jurisdictions, it is not possible to place a pharmaceutical product on the market without first having registered that product with the relevant authorities (subject to limited exceptions which we do not explore further in this article).

In the UAE for example, the application must be prepared and submitted in the joint names of the manufacturer who holds a marketing authorisation for the product in its home jurisdiction and the local representative. The local representative can be the distributor of the products as long as: (i) it has the ability to act as the authorised representative in relation to the manufacturer's obligations and responsibilities; and (ii) it has been appointed by the manufacturer to act as authorised representative. The local representative will be responsible for post-market surveillance of the product and for dealing with the relevant authorities in relation to the product. Alternatively, the manufacturer can appoint a separate local representative under a suitable contract.

The precise paperwork which is to be submitted as part of the application will vary but in general, the documentation to be submitted with the application may include:

a certificate stating that the products have been manufactured in conformity with the laws of the country in which they are manufactured;

  • a 'free of sale' certificate;
  • a certificate stating that the products can be manufactured and exported from the manufacturing country;
  • documentation relating to the site at which the products are manufactured;
  • documentation detailing the approved use of the product;
  • documentation detailing safe use and precautions for the products;
  • a copy of the product's instructions for use;
  • copies of the labelling to be used on the product;
  • an audit plan; and
  • a pharmacovigilance plan for the product.

Manufacturers should note that the regulatory authorities can ask for additional documentation to be submitted once they begin their review of the application.

Distribution Agreements – Treatment of marketing authorisations

Given that the distributor acting as a local representative may be required to hold the marketing authorisations in its name, manufacturers should consider how those marketing authorisations will be: (i) transferred to a new distributor; or (ii) deregistered and reregistered in the name of the new distributor on expiry or termination of the underlying agreement.

In some jurisdictions, it may be possible to draft a contract so that the distributor holds the marketing authorisation on trust for the manufacturer. However, this common law concept is not widely recognised in the region.

Alternatively, it may be possible for the distributor to grant the manufacturer's nominee a power of attorney to transfer/deregister the marketing authorisations on behalf of the distributor. Again, this may not work in all jurisdictions due to restrictions on the granting of powers of attorney.


Obtaining marketing approval to sell pharmaceutical products in the UAE is not dissimilar to the process in other jurisdictions. However, overseas manufacturers who do not have a legal presence in the region should also consider how the commercial agency laws will impact their operations.

Distribution Of Pharmaceutical Products Through A Local Partner In The GCC

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.